Cargando…

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition

The high incidence of recurrence and the poor prognosis of hepatocellular carcinoma (HCC) necessitate the discovery of new predictive markers of HCC invasion and prognosis. In this study, we evaluated the expression pattern of two members of a novel oncogene family, Musashi1 (MSI1) and Musashi2 (MSI...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Lu, Zhou, Xinke, Qu, Chen, Hu, Lijuan, Tang, Yunqiang, Zhang, Qiong, Liang, Min, Hong, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916117/ https://www.ncbi.nlm.nih.gov/pubmed/24305552 http://dx.doi.org/10.1111/jcmm.12158

Ejemplares similares

HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition
por: Li, Pin-Dong, et al.
Publicado: (2018)

Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition
por: Song, Tao, et al.
Publicado: (2018)

RETRACTED ARTICLE: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2017)

Retraction Note: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2018)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
por: Zhou, Rui, et al.
Publicado: (2017)

Overexpression of Musashi-1 protein is associated with progression and poor prognosis of gastric cancer
por: Shou, Zhangxuan, et al.
Publicado: (2017)

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
por: Xiao, Shuai, et al.
Publicado: (2016)

PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
por: Peng, Yanghong, et al.
Publicado: (2018)

Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis
por: Zhang, Yixi, et al.
Publicado: (2020)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases
por: Margarido, Andreia S., et al.
Publicado: (2022)

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer
por: Kurashige, Junji, et al.
Publicado: (2019)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis
por: Liu, Qiuhua, et al.
Publicado: (2019)

Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer
por: Zong, Zhen, et al.
Publicado: (2016)

HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
por: Xia, You-You, et al.
Publicado: (2015)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition
por: Chen, Xin, et al.
Publicado: (2017)

Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer
por: Yang, Ziguo, et al.
Publicado: (2019)

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
por: Liu, Wen-Fang, et al.
Publicado: (2012)

High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial–mesenchymal transition in gastric cancer
por: Yan, Yan, et al.
Publicado: (2016)

MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial–Mesenchymal Transition In Gastric Cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection
por: Wang, Cheng-Hao, et al.
Publicado: (2015)

Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human Glioma
por: Lv, Qiao-Li, et al.
Publicado: (2016)

Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery
por: HUANG, MINGSHENG, et al.
Publicado: (2016)

NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition
por: Tong, Hui, et al.
Publicado: (2020)

CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer
por: Woischke, Christine, et al.
Publicado: (2016)

MACC1 Is Associated With Epithelial–Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma
por: Cheng, Hao, et al.
Publicado: (2021)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

Upregulation of DUSP14 Affects Proliferation, Invasion and Metastasis, Potentially via Epithelial–Mesenchymal Transition and Is Associated with Poor Prognosis in Pancreatic Cancer
por: Wei, Yajun, et al.
Publicado: (2020)

Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2018)

Comment on ‘Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?’
por: Liu, Yuying, et al.
Publicado: (2018)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition
por: Chen, Hao, et al.
Publicado: (2016)

Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance
por: Zhang, Yan, et al.
Publicado: (2016)

PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition
por: Yang, Yang, et al.
Publicado: (2022)

Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer
por: Liu, Chen-Chi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_csk5m0spc652t12i86amq6j7lu